Literature DB >> 30814362

Proteases Upregulation in Sporadic Alzheimer's Disease Brain.

Alessandro Medoro1, Silvia Bartollino1, Donatella Mignogna1, Nicola Marziliano1,2, Carola Porcile1, Mario Nizzari3, Tullio Florio3,4, Aldo Pagano5,4, Gennaro Raimo1, Mariano Intrieri1, Claudio Russo1.   

Abstract

Certain proteases are involved in Alzheimer's disease (AD) and their erroneous control may contribute to the pathology onset and progression. In this study we evaluated the cerebral expression of eight proteases, involved in both AβPP processing and extracellular matrix remodeling. Among these proteases, ADAM10, ADAMTS1, Cathepsin D, and Meprin β show a significantly higher mRNAs expression in sporadic AD subjects versus controls, while ADAMTS1, Cathepsin D, and Meprin β show an increment also at the protein level. These data indicate that transcriptional events affecting brain proteases are activated in AD patients, suggesting a link between proteolysis and AD.

Entities:  

Keywords:  ADAMTS1; Alzheimer’s disease; Cathepsin D; Meprin β; RT-PCR; cancer; western blot; α-secretase

Year:  2019        PMID: 30814362     DOI: 10.3233/JAD-181284

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  7 in total

1.  Meprin β: A novel regulator of blood-brain barrier integrity.

Authors:  Markus Gindorf; Steffen E Storck; Anke Ohler; Franka Scharfenberg; Christoph Becker-Pauly; Claus U Pietrzik
Journal:  J Cereb Blood Flow Metab       Date:  2020-02-16       Impact factor: 6.200

2.  Phosphorylation of the amyloid precursor protein (APP) at Ser-675 promotes APP processing involving meprin β.

Authors:  Preeti Kumaran Menon; Niina Anneli Koistinen; Kerstin Iverfeldt; Anna-Lena Ström
Journal:  J Biol Chem       Date:  2019-10-11       Impact factor: 5.157

Review 3.  The Intersection between COVID-19, the Gene Family of ACE2 and Alzheimer's Disease.

Authors:  Mahdi Montazer Haghighi; Erfan Ghani Kakhki; Christine Sato; Mahdi Ghani; Ekaterina Rogaeva
Journal:  Neurosci Insights       Date:  2020-11-22

4.  Associations of Alzheimer's disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration.

Authors:  Meng-Shan Tan; Yu-Xiang Yang; Wei Xu; Hui-Fu Wang; Lin Tan; Chuan-Tao Zuo; Qiang Dong; Lan Tan; John Suckling; Jin-Tai Yu
Journal:  Alzheimers Res Ther       Date:  2021-01-08       Impact factor: 6.982

5.  Meprin β knockout reduces brain Aβ levels and rescues learning and memory impairments in the APP/lon mouse model for Alzheimer's disease.

Authors:  Liana Marengo; Fred Armbrust; Caroline Schoenherr; Steffen E Storck; Ulrich Schmitt; Silvia Zampar; Oliver Wirths; Hermann Altmeppen; Markus Glatzel; Christoph Kaether; Sascha Weggen; Christoph Becker-Pauly; Claus U Pietrzik
Journal:  Cell Mol Life Sci       Date:  2022-03-02       Impact factor: 9.207

6.  Altered Balance of Reelin Proteolytic Fragments in the Cerebrospinal Fluid of Alzheimer's Disease Patients.

Authors:  Inmaculada Lopez-Font; Matthew P Lennol; Guillermo Iborra-Lazaro; Henrik Zetterberg; Kaj Blennow; Javier Sáez-Valero
Journal:  Int J Mol Sci       Date:  2022-07-07       Impact factor: 6.208

Review 7.  Low-Density Lipoprotein Receptor-Related Protein 8 at the Crossroad between Cancer and Neurodegeneration.

Authors:  Daniela Passarella; Silvia Ciampi; Valentina Di Liberto; Mariachiara Zuccarini; Maurizio Ronci; Alessandro Medoro; Emanuele Foderà; Monica Frinchi; Donatella Mignogna; Claudio Russo; Carola Porcile
Journal:  Int J Mol Sci       Date:  2022-08-10       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.